ICON Public Limited (NASDAQ:ICLR - Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 2,280,000 shares, a growth of 41.6% from the March 15th total of 1,610,000 shares. Approximately 2.8% of the shares of the company are short sold. Based on an average trading volume of 1,030,000 shares, the short-interest ratio is currently 2.2 days.
Analyst Ratings Changes
Several brokerages have recently weighed in on ICLR. Royal Bank of Canada reiterated an "outperform" rating and set a $263.00 price target on shares of ICON Public in a research report on Wednesday, January 15th. The Goldman Sachs Group cut shares of ICON Public from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $250.00 to $200.00 in a research note on Friday, March 21st. Barclays restated an "equal weight" rating and set a $165.00 price target (down from $240.00) on shares of ICON Public in a research report on Thursday, April 10th. Citigroup lowered their price objective on ICON Public from $290.00 to $215.00 and set a "buy" rating on the stock in a research report on Monday, April 7th. Finally, TD Cowen cut ICON Public from a "buy" rating to a "hold" rating and reduced their target price for the stock from $254.00 to $157.00 in a research report on Monday, April 14th. Seven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $232.67.
View Our Latest Stock Report on ICON Public
Hedge Funds Weigh In On ICON Public
Institutional investors and hedge funds have recently made changes to their positions in the business. Sierra Ocean LLC bought a new position in ICON Public during the 4th quarter valued at approximately $29,000. Park Place Capital Corp increased its holdings in shares of ICON Public by 281.4% during the fourth quarter. Park Place Capital Corp now owns 225 shares of the medical research company's stock valued at $47,000 after acquiring an additional 166 shares in the last quarter. Private Trust Co. NA raised its position in shares of ICON Public by 48.8% in the 4th quarter. Private Trust Co. NA now owns 250 shares of the medical research company's stock worth $52,000 after purchasing an additional 82 shares during the last quarter. NBC Securities Inc. purchased a new position in shares of ICON Public in the 1st quarter worth about $59,000. Finally, GAMMA Investing LLC boosted its stake in ICON Public by 64.0% in the 4th quarter. GAMMA Investing LLC now owns 433 shares of the medical research company's stock worth $91,000 after purchasing an additional 169 shares in the last quarter. Institutional investors own 95.61% of the company's stock.
ICON Public Trading Down 3.0 %
ICLR traded down $4.29 during trading on Friday, hitting $139.26. 1,758,848 shares of the stock traded hands, compared to its average volume of 905,951. The firm has a market capitalization of $11.25 billion, a P/E ratio of 14.61, a price-to-earnings-growth ratio of 1.86 and a beta of 1.24. ICON Public has a 12-month low of $137.87 and a 12-month high of $347.72. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.26 and a quick ratio of 1.34. The firm has a 50-day moving average of $174.62 and a 200 day moving average of $205.82.
ICON Public (NASDAQ:ICLR - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The medical research company reported $3.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.41 by $0.01. ICON Public had a return on equity of 11.81% and a net margin of 9.56%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.04 billion. Equities research analysts anticipate that ICON Public will post 13.38 EPS for the current year.
About ICON Public
(
Get Free Report)
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ICON Public, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICON Public wasn't on the list.
While ICON Public currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
